AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026Net selling: insiders sold $43K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$43K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 7- Open
- $225.00
- 52-wk high
- $226.16
- High
- $226.16
- 52-wk low
- $83.99
- Low
- $217.46
- Prev close
- $225.00
- Mkt cap
- $1.54B
- P/E
- 8.9x
- Volume
- 122.8K
- Beta
- 2.00
- P/S
- 1.8x
- P/B
- 3.5x
- Profit margin
- +21.2%
- Op margin
- +57.8%
- ROE
- +64.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about NUTX filings
Are insiders buying or selling Nutex Health Inc (NUTX) stock?
Net selling: insiders sold $43K and bought $0 of NUTX stock on the open market in the 90 days to Oct 7, 2026, according to SEC Form 4 filings. The largest was Saunders, Scott J (Director), who sold $43K. The latest filing was on Sep 18, 2026.
Which members of Congress have traded NUTX recently?
None. No member of Congress disclosed a NUTX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this NUTX smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
Sells (1)
- SS
Saunders Scott J
$43K
sold
How top traders are positioned
No tracked top-trader positions in NUTX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 82.1% above what analysts expected.
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$5.26 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $9.58 / $5.26Alpha Vantage | +82.13% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $5.74 / $5.56Yahoo Finance | +3.25% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 5, 2026 | $1.62 / $5.56Alpha Vantage | -70.85% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 19, 2025 | $7.76 / $1.95Yahoo Finance | +$5.81 beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jun 30, 2025 | $5.23 / -$5.43Alpha Vantage | +$10.66 beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 13, 2025 | $1.78 / $3.91Alpha Vantage | -54.48% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | $11.12 / -$0.12Alpha Vantage | +$11.24 beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 8, 2024 | -$0.32 / $0.28Alpha Vantage | -$0.60 miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 18, 2026, in 42 days
Financials
Is the business strong?
Fairly priced and profitable.
- Net margin
- 21.2%
- P/E
- 8.91
- Market cap
- $1.5B
Valuation
- P/S1.82
- P/B3.50
Quality
- Operating margin57.8%
- ROE64.6%
- ROA33.3%
Growth
- Beta2.00
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace